CoChat

Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3

Open access
Lipina, Tatiana V., Kaidanovich‐Beilin, Oksana, Patel, Satish, Wang, Min, Clapcote, Steven J., Liu, Fang, Woodgett, James R., Roder, John C. · 2011 · Synapse
Cited by 91

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Recent studies have identified disrupted‐in‐schizophrenia‐1 (DISC1) as a strong genetic risk factor associated with schizophrenia. Previously, we have reported that a mutation in the second exon of the DISC1 gene [leucine to proline at amino acid position 100, L100P] leads to the development of schizophrenia‐related behaviors in mice. Glycogen synthase kinase‐3 (GSK‐3) is a serine/threonine protein kinase that interacts with the N‐terminal region of DISC1 (aa 1–220) and has been implicated as an important downstream component in the etiology of schizophrenia. Here, for the first time, we show that pharmacological and genetic inactivation of GSK‐3 reverse prepulse inhibition and latent inhibition deficits as well as normalizing the hyperactivity of Disc1‐L100P mutants. In parallel to these observations, interaction between DISC1 and GSK‐3α and β is reduced in Disc1‐L100P mutants. Our data provide genetic, biochemical, and behavioral evidence for a molecular link between DISC1 and GSK‐3 in relation to psychopathology and highlights the value of missense mutations in dissecting the underlying and complex molecular mechanisms of neurological disorders. Synapse, 2010. © 2010 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/syn.20839

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 91

Metadata

Authors
Lipina, T. V., Kaidanovich‐Beilin, O., Patel, S., Wang, M., Clapcote, S. J., Liu, F., Woodgett, J. R., & Roder, J. C.
Venue
Synapse
Publisher
Wiley
Published
2010-12-28
Volume
65
Issue
3
Pages
234-248
ISSN
  • 0887-4476 (ISSN-L)
  • 1098-2396
OpenAlex
W2096891080
Cited by
91
References
17
FWCI
7.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3. https://app.cochat.ai/papers/10.1002/syn.20839
The paper
Lipina, T. V., Kaidanovich‐Beilin, O., Patel, S., Wang, M., Clapcote, S. J., Liu, F., Woodgett, J. R., & Roder, J. C. (2011). Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3. Synapse. https://doi.org/10.1002/syn.20839

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.